Technology Insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning

Nature Clinical Practice Oncology

Volumn 2, Issue 10, 2005, Pages 526-533

  Frank, Steven J ^a   Chao, K S Clifford ^a   Schwartz, David L ^a   Weber, Randal S ^a   Apisarnthanarax, Smith ^a   Macapinlac, Homer A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Head and neck cancer; PET CT; Radiation therapy; Treatment planning

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MOTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; TREATMENT PLANNING;

FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 27644562324     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0322     Document Type: Review

References (52)

1. Carvalho AL et al. (2005) Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database. Int J Cancer 114: 806-816
2. Cooper JS et al. (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350: 1937-1944
3. Bernier J et al. (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350: 1945-1952
4. Ginsberg LE (2002) MR imaging of perineural tumor spread. Magn Reson Imaging Clin N Am 10: 511-525
5. Takashima S et al. (1992) Head and neck carcinoma: Detection of extraorgan spread with MR imaging and CT. Eur J Radiol 14: 228-234
6. Gwyther SJ (1994) Modern techniques in radiological imaging related to oncology. Ann Oncol 5 (Suppl 4): S3-S7
7. Antoch G et al. (2003) Non-small cell lung cancer: Dual-modality PET/CT in preoperative staging. Radiology 229: 526-533
8. Steinert HC (2004) PET/CT in lymphoma patients. Radiologe 44: 1060-1067
9. Goerres GW et al. (2005) The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: Long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging 32: 153-162
10. Patel PV et al. (2002) PET-CT localizes previously undetectable metastatic lesions in recurrent fallopian tube carcinoma. Gynecol Oncol 87: 323-326
11. Veit P et al. (2005) Whole-body PET/CT tumour staging with integrated PET/CT-colonography: Technical feasibility and first experiences in patients with colorectal cancer. Gut [doi: 10.1136/gut.2005.064170]
12. Zangheri B et al. (2004) PET/CT and breast cancer. Eur J Nucl Med Mol Imaging 31 (Suppl 1): S135-S142
13. Antoch G et al. (2003) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290: 3199-3206
14. Bar-Shalom R et al. (2003) Clinical performance of PET/CT in evaluation of cancer: Additional value for diagnostic imaging and patient management. J Nucl Med 44: 1200-1209
15. Schwartz DL et al. (2005) FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 61: 129-136
16. Schoder H et al. (2004) Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion. Radiology 231: 65-72
17. 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: Preliminary results in 21 patients. Eur J Nucl Med Mol Imaging 32: 589-592
18. Gutzeit A et al. (2005) Unknown primary tumors: Detection with dual-modality PET/CT - initial experience. Radiology 234: 227-234
19. Kim EE et al. (2004) Clinical PET: Principles and Applications. New York: Springer
20. Clarke JC (2004) PET/CT "Cometh the hour, cometh the machine?" Clin Radiol 59: 775-776
21. Goerres GW et al (2004) Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med 45 (Suppl 1): S66-S71
22. Lardinois D et al. (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348: 2500-2507
23. Ling CC et al. (2000) Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47: 551-560
24. Apisarnthanarax S and Chao KS (2005) Current imaging paradigms in radiation oncology. Radiat Res 163: 1-25
25. Ciernik IF et al. (2003) Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. Int J Radiat Oncol Biol Phys 57: 853-863
26. 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy. J Neurosurg 101 (Suppl 3): S381-S389
27. Chao KS et al. (2001) A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49: 1171-1182
28. 18F-FDG PET on staging and managing patients for radiation therapy. J Nucl Med 44: 24-29
29. Koshy M et al. (2005) F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck 27: 494-502
30. Paulino AC et al. (2005) Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 61: 1385-1392
31. 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 53: 1051-1057
32. 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors. Strahlenther Onkol 174: 358-364
33. Scarfone C et al. (2004) Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 45: 543-552
34. Heron DE et al. (2004) Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: A brief technical report. Int J Radiat Oncol Biol Phys 60: 1419-1424
35. Golder WA (2004) Lymph node diagnosis in oncologic imaging: A dilemma still waiting to be solved. Onkologie 27: 194-199
36. Findlay M et al. (1996) Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: Correlation with tumor response to fluorouracil. J Clin Oncol 14: 700-708
37. Kostakoglu L et al. (2004) PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics 24: 1411-1431
38. Mineura K et al. (1996) Long-term positron emission tomography evaluation of slowly progressive gliomas. Eur J Cancer 32A: 1257-1560
39. Kubota K (2001) From tumor biology to clinical PET a review of positron emission tomography (PET) in oncology. Ann Nucl Med 15: 471-486
40. Lee JK and Glazer HS (1990) Controversy in the MR imaging appearance of fibrosis. Radiology 177: 21-22
41. Lowe VJ et al. (2000) Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 18: 651-658
42. Brun E et al. (2002) FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24: 127-135
43. Hautzel H and Muller-Gartner HW (1997) Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 38: 1384-1386
44. Rege S et al. (1994) Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 73: 3047-3058
45. Fukui MB et al. (2003) PET/CT imaging in recurrent head and neck cancer. Semin Ultrasound CT MR 24: 157-163
46. Yao M et al. (2004) The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 59: 1001-1010
47. Yao M et al. (2005) Can post-RT FDG PET accurately predict the pathologic status in neck dissection after radiation for locally advanced head and neck cancer? Int J Radiat Oncol Biol Phys 61: 306-307
48. Rogers JW et al. (2004) Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 58: 694-697
49. Greven KM et al. (2001) Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23: 942-946
50. Stenson KM et al. (2000) The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: The feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 126: 950-956
51. Zimmer LA et al. (2005) The use of combined PET/CT for localizing recurrent head and neck cancer: The Pittsburgh experience. Ear Nose Throat J 84: 108-110
52. Bucci MK et al. (2005) Advances in radiation therapy: Conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin 55: 117-134